REAKSI Drug Safety News

Reaksi Drug Safety News 2017 - Issue 5/2017

Written by Jauze · 16 October 2017

Reaksi Drug Safety News 2017,

Issue 5/2017

 

  • Vemurafenib: Risk of Dupuytren’s Contracture and Plantar Fascial Fibromatosis
  • Leflunomide and Teriflunomide: Risk of Falsely Decreased Ionised Calcium Levels and Risk of Colitis

 

 

  
  DOWNLOAD PDF

 

 

 

Rate this page

Not yet rated

Share on Facebook Share on X Share on WhatsApp Share on LinkedIn
Page tools
Email
All publications